Average cost of drugs for extensively drug-resistant tuberculosis in Central African Republic
Central African Republic: Average cost of drugs for extensively drug-resistant tuberculosis was 1,500 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
1,500 constant 2022 US$
Change on year
unchanged
World rank
33rd
of 56 countries
All-time high
2,500 constant 2022 US$
in 2017
All-time low
1,500 constant 2022 US$
in 2019
Years of data
6
2017–2024
Average cost of drugs for extensively drug-resistant tuberculosis in Central African Republic, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Central African Republic recorded 1,500 constant 2022 US$ for average cost of drugs for extensively drug-resistant tuberculosis in 2024. That is the lowest value across all 6 years on record.
That represents a change of down 40.0% over ten years.
That places Central African Republic 33rd out of 56 countries with data for 2024, putting it in the middle of the range.
Average cost of drugs for extensively drug-resistant tuberculosis in Central African Republic, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 2,500 constant 2022 US$ | — |
| 2019 | 1,500 constant 2022 US$ | -40.0% |
| 2020 | 1,500 constant 2022 US$ | +0.0% |
| 2022 | 1,500 constant 2022 US$ | +0.0% |
| 2023 | 1,500 constant 2022 US$ | +0.0% |
| 2024 | 1,500 constant 2022 US$ | +0.0% |
Central African Republic compared with similar countries
- Central African Republic's 1,500 constant 2022 US$ is below the median for low income countries, which is 1,709 constant 2022 US$, 88% of the median. (9 countries reporting)
- Central African Republic's 1,500 constant 2022 US$ is above the median for Sub-Saharan Africa, which is 1,500 constant 2022 US$, 1.0× the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,000 constant 2022 US$ | 1,500 constant 2022 US$ | 2,500 constant 2022 US$ | 2 |
| 2020s | 1,500 constant 2022 US$ | 1,500 constant 2022 US$ | 1,500 constant 2022 US$ | 4 |
Countries ranked near Central African Republic
More reference data data for Central African Republic
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.1959 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 3.03 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 3.26 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.0271 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 3.26 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.6569 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.7203 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 15.38 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 16.95 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.1476 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Central African Republic?
- Average cost of drugs for extensively drug-resistant tuberculosis in Central African Republic was 1,500 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Central African Republic?
- The highest recorded value was 2,500 constant 2022 US$ in 2017.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Central African Republic?
- The lowest recorded value was 1,500 constant 2022 US$ in 2019.
- How does Central African Republic rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Central African Republic ranks 33rd out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Central African Republic?
- Over the last ten years it is down 40.0%. The long-run trend across the full record is falling.
- Where does this Central African Republic data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.